Scholar Rock Holding Corp (SRRK)
27.49
+0.11
(+0.40%)
USD |
NASDAQ |
Nov 14, 16:00
27.50
+0.01
(+0.04%)
After-Hours: 17:18
Scholar Rock Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2022 | 0.293 |
| December 31, 2021 | 0.2906 |
| September 30, 2021 | 0.1331 |
| June 30, 2021 | 0.1147 |
| March 31, 2021 | 0.1029 |
| December 31, 2020 | 0.0946 |
| September 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.0028 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.293
Maximum
Mar 2022
0.1029
Average
0.0988
Median
Debt to Equity Ratio Benchmarks
| Cytokinetics Inc | -47.16 |
| Regeneron Pharmaceuticals Inc | 0.0677 |
| Ocugen Inc | 0.1688 |
| Mirum Pharmaceuticals Inc | 1.342 |
| NeuroBo Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 226.86M |
| Total Liabilities (Quarterly) | 93.24M |
| Shareholders Equity (Quarterly) | 133.62M |